| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
110.25(B) |
| Last
Volume: |
6,013,077 |
Avg
Vol: |
8,376,873 |
| 52
Week Range: |
$48.64 - $77.42 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
304,513 |
503,645 |
996,293 |
2,118,674 |
| Total Sell Value |
$22,679,618 |
$34,760,114 |
$60,765,476 |
$110,963,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
26 |
43 |
79 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nicholas Peter M |
Director |
– • – |
2009-01-22 |
4 |
AS |
$7.84 |
$784,400 |
I/I |
(100,000) |
17,030,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-21 |
4 |
AS |
$7.71 |
$770,500 |
D/D |
(100,000) |
31,383,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-21 |
4 |
AS |
$7.71 |
$770,500 |
I/I |
(100,000) |
17,130,032 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-20 |
4 |
AS |
$7.64 |
$764,000 |
I/I |
(100,000) |
17,230,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-20 |
4 |
AS |
$7.64 |
$764,000 |
D/D |
(100,000) |
31,483,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-16 |
4 |
AS |
$7.78 |
$778,000 |
I/I |
(100,000) |
17,330,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-16 |
4 |
AS |
$7.78 |
$778,000 |
D/D |
(100,000) |
31,583,029 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-15 |
4 |
AS |
$7.40 |
$740,300 |
D/D |
(100,000) |
31,683,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-15 |
4 |
AS |
$7.40 |
$740,300 |
I/I |
(100,000) |
17,430,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-14 |
4 |
AS |
$7.28 |
$727,900 |
D/D |
(100,000) |
31,783,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-14 |
4 |
AS |
$7.28 |
$727,900 |
I/I |
(100,000) |
17,530,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-13 |
4 |
AS |
$7.39 |
$739,000 |
D/D |
(100,000) |
31,883,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-13 |
4 |
AS |
$7.39 |
$739,000 |
I/I |
(100,000) |
17,630,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-12 |
4 |
AS |
$7.44 |
$744,100 |
D/D |
(100,000) |
31,983,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-12 |
4 |
AS |
$7.44 |
$744,100 |
I/I |
(100,000) |
17,730,032 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-09 |
4 |
AS |
$7.72 |
$771,500 |
I/I |
(100,000) |
17,830,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-09 |
4 |
AS |
$7.72 |
$771,500 |
D/D |
(100,000) |
32,083,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-08 |
4 |
AS |
$7.68 |
$768,100 |
I/I |
(100,000) |
17,930,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-08 |
4 |
AS |
$7.68 |
$768,100 |
D/D |
(100,000) |
32,183,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-07 |
4 |
AS |
$7.89 |
$789,400 |
I/I |
(100,000) |
18,030,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-07 |
4 |
AS |
$7.89 |
$789,400 |
D/D |
(100,000) |
32,283,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-06 |
4 |
AS |
$7.93 |
$792,600 |
I/I |
(100,000) |
18,130,032 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-01-06 |
4 |
AS |
$7.93 |
$792,600 |
D/D |
(100,000) |
32,383,029 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2009-01-05 |
4 |
D |
$7.56 |
$1,724 |
D/D |
(228) |
9,595 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-01-05 |
4 |
AS |
$7.70 |
$770,000 |
I/I |
(100,000) |
18,230,032 |
|
- |
|
1823 Records found
|
|
Page 58 of 73 |
|
|
0.41 (0.53%) 
